Short answer
GE HealthCare (GEHC) filed its Q3 2025 10-Q quarterly report on Oct 29, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $5.1B (up 5.7% year over year) with net income of $446M.
Q3 2025 key financials · XBRL
- Revenue
- $5.1B
- +5.7% YoY · +2.7% QoQ
- Net income
- $446M
- −5.1% YoY · −8.0% QoQ
- Operating margin
- 12.7%
- Gross margin
- 38.7%
- EPS (diluted)
- $0.97
- −4.9% YoY · −8.5% QoQ
Source: XBRL data from the GE HealthCare (GEHC) Q3 2025 10-Q on SEC EDGAR. USD.
GE HealthCare Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $5,143M, up 6% YoY from $4,863M; nine-month revenue $14,927M, up 4% YoY from $14,353M
- Operating margin 12.7% vs 13.9% YoY Q3; nine-month operating margin 13.0% vs 12.7% YoY, net income margin 10.0% vs 8.9% YoY
- Best segment: PDx revenue up 20% to $749M with 29.4% EBIT margin; worst segment: PCS revenue down 6% to $731M with 3.7% EBIT margin
- Cash from operating activities $937M (9-month), free cash flow $589M, capital expenditures $348M, financed by $1,487M senior debt issuance
- Management highlights tariff-driven cost inflation impacting margins, slower recovery in China market, expects continued tariff impact and geopolitical risks
Risk Factors
- No material changes to risk factors from fiscal 2024 10-K disclosed this quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other GE HealthCare quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.